Prosecution Insights
Last updated: November 04, 2026
Application No. 19/051,210

System for Assessing Global Wellness

Final Rejection §101
Filed
Feb 12, 2025
Priority
Jun 28, 2014 — provisional 62/018,542 +3 more
Examiner
ELSHAER, ALAAELDIN M
Art Unit
3687
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Relevance Health
OA Round
2 (Final)
36%
Grant Probability
At Risk
3-4
OA Rounds
1y 5m
Est. Remaining
66%
With Interview

Examiner Intelligence

Grants only 36% of cases
36%
Career Allowance Rate
80 granted / 223 resolved
-16.1% vs TC avg
Strong +30% interview lift
Without
With
+29.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
34 currently pending
Career history
270
Total Applications
across all art units

Statute-Specific Performance

§101
37.8%
-2.2% vs TC avg
§103
37.6%
-2.4% vs TC avg
§102
6.5%
-33.5% vs TC avg
§112
13.7%
-26.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 223 resolved cases

Office Action

§101
DETAILED ACTION This office action is based on the claim filed on 08/20/2026. Claim 5 is new. Claims 1-5 are currently pending and have been examined. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election by Original Presentation Newly submitted Claim 5 is directed to an invention that is independent or distinct from the invention originally claimed for the following reasons: The inventions are independent or distinct, each from the other because the inventions of the following groups are related as combination and sub-combination. Claims 1-4 are drawn to a method detecting periodontal diseases and systemic health and analyzing biological sample, classified in G01N33/56955, G01N33/50 and, G16H50/30. Claim 5, is drawn to a wearable device and wireless components, classified in G06Q20/321 and G06Q30/0267. Inventions in this relationship are distinct if it can be shown that (1) the combination as claimed does not require the particulars of the sub-combination as claimed for patentability, and (2) that the sub-combination has utility by itself or in other combinations (MPEP § 806.05(c)). In the instant case, the combination (Group I) as claimed does not require the particulars of the sub-combinations as claimed because: Group II claims include a wearable device comprising computing components, which are not present in the combination. The sub-combination has separate utility such as hardware construction. The sub-combination has separate utility such as a wearable device comprising computing components such as biosensor, wireless receiver and transmitter, readable storage medium. Further, there would be a serious search burden place upon the examiner as indicated by tile different subject matter and the differing classifications or the inventions (see above). The examiner has required restriction between combination and sub-combination inventions. Applicant is advised that it any claim presented in a continuation or divisional application is anticipated by, or includes all the limitations of, a claim that is allowable in the present application, such claim may be subject to provisional statutory and/or non-statutory double patenting rejections over the claims of the instant application. Since applicant has received an action on the merits for the originally presented invention present in Group I claims, this invention has been constructively elected by original presentation for prosecution on the merits. Accordingly, Claim 5 is withdrawn from consideration as being directed to a non-elected invention. See 37 CFR 1.142(b) and MPEP §821.03. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claim 1-4 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Claims 1-2 are drawn to a method and Claims 3-4 are directed to a system, and each of which is within the four statutory categories (i.e., a machine and a process). Claims 1-4 are further directed to an abstract idea on the grounds set out in detail below. Under Step 2A, Prong 1, the steps of the claim for the invention represents an abstract idea of a series of steps that recite a process for analyzing a subject health data, provide and monitor treatment plan to improve subject’s health. Collecting dental, medical and genetic records to be analyzed are steps that could have been performed by a human performing the steps following instruction to collect and analyze subject data to provide a treatment plan but for the fact that the claims recite a general-purpose computer processor to implement the abstract idea for which both the instant claims and the abstract idea are defined as Methods of Organizing Human Activity. Independent Claim 1 recites the steps of: “(i) obtaining and recording on digital storage media dental, medical and genetic historical data from the subject; (ii) performing a current periodontal analysis and dental diagnosis, and taking an oral sample from the subject; (iii) assaying the oral sample for indication of:(a) pathogenic microorganisms;(b) endogenous genetic biomarkers of inflammation or disease; and/or (c) specific hormones or lipids; (iv) using a computer program to simultaneously assess and compare information gathered in (i) to digital landscape of data points and an ideal wellness digital landscape of endpoints; (v) superimposing the initial and the ideal digital landscapes and calculating, in silico, simulated movement paths between the initial untreated data points and the ideal wellness target endpoints according to a minimum step criterion, each simulated movement path beginning a data point in the initial untreated digital landscape and ending at the corresponding ideal wellness target endpoint; (vi) dividing each simulated movement path into intermediate steps for the patient to progress toward the ideal wellness endpoint; (vii) communicating the (viii) optionally, providing to the subject tracking device and progress indicator that displays a readout to the subject transmits to the cloud and records the subject's progress along the paths; wherein, when the subject implements the treatment plan, the subject progresses toward the ideal wellness target endpoints and the method thereby treats and improves global wellness in the subject”. Independent Claim 3 recites the steps of: “(i) a computer-readable storage medium comprising recorded medical and dental history data points from the subject; (ii) a sample-collection and measuring apparatus for obtaining an oral sample from the subject, comprising a plurality of analyte detection regions that test for the presence of and measure current levels of at least one of : (a) proteins and nucleic acids from bacteria, viruses or other pathogens; and/or (b) endogenous genetic biomarkers of inflammation, infection, and autoimmune disease; and/or (c) specific hormones or lipids; (iii) results from a current periodontal analysis; (iv) a computer program that simultaneously assesses and compares the medical and dental history data points of (i), the presence of and/or current levels from the analyte detection regions of (ii), and the results from the current periodontal analysis of (iii) to a stored reference set of desired health and wellness goals, identifies oral-systemic links, generates an initial digital wellness landscape and a restored digital wellness landscape, superimposes the initial and the ideal digital wellness landscapes, and calculates, in silico, comprising a series of behavioral steps according to a minimum step criterion, such that, when the behavioral steps are performed by the subject, the subject is treated and improves in global systemic wellness” Independent Claim 4 recites the steps of: “(i) a computer-readable storage medium comprising stored medical and dental history from a subject and stored results from current dental diagnostic tests and current periodontal analysis; (ii) a database comprising a reference set of target indices representing ideal dental and medical health and wellness endpoints in a computer-readable storage medium; (iii) a sample-collection component for obtaining an oral sample from the subject, and testing for: (a) pathogenic microorganisms;(b) endogenous genetic and polypeptide biomarkers indicative or predictive of disease or inflammation; and/or (c) levels of specific hormones or lipids; and (iv) a receiver of inputted data from (iii)(a)-(c) (v) a transmitter; (vi) a computer program that: (d) simultaneously assesses and compares information gathered from the computer-readable storage medium of (i), the database of (ii), the results from the tests of (i) and (iii); (e) identifies an oral-systemic link between at least one indicator of disease in the oral cavity and at least one pathogen, biomarker, hormone or lipid level tested in (iii)(a)-(c); (f) generates an initial digital wellness landscape and a restored digital wellness landscape, and optionally, an intermediate digital wellness landscape; (g) aligns the initial digital wellness landscape with the restored digital wellness landscape and optional intermediate digital wellness landscape, and (h) simulates a set of simulated movement path between the initial digital wellness landscape and the restored digital wellness landscape; and (i) computes, according to a minimum step criterion, a treatment plan of steps to move the subject from an initial state to a restored state of wellness”. These limitations, as drafted, given the broadest reasonable interpretation, cover performance of the limitations by a human user/actor interacting with a computing system and apparatus that constitute Certain Methods of Organizing Human activity (following instructions to determine recommended treatment) along with Mental Process/Mathematical concepts, but for the recitation of generic computer components. The limitations encompass a user the ability to collect a subject dental, medical and genetic records, analyzing the data and compare it against a reference to identify oral link to a systemic condition and provide a treatment plan, which are steps that could be performed by a human actor interacting with other user(s) and/or a machine as such identifying an abstract idea. This abstract idea could have been performed by a human actor but for the fact that the claims recite a general-purpose computer processor to implement the abstract idea for generating a treatment plan to improve health of a subject. If a claim limitation(s), under its broadest reasonable interpretation, covers performance of the limitation(s) by a human actor but for the recitation of generic computer components, then it falls within the “Certain Methods of Organizing Human Activity” (following instructions to determine recommended treatment), grouping of abstract ideas. Accordingly, the claim limitations (in BOLD) recite an abstract idea. Any limitations not identified above as part of methods of organizing human activity are deemed "additional elements," and will be discussed in further detail below. Under Step 2A, Prong 2, this judicial exception is not integrated into a practical application because the remaining elements amount to no more than general purpose computer components programmed to perform the abstract ideas, linking the abstract idea to a particular technological environment. In particular, the claims recite the additional elements such as “processor, digital storage media, computer-readable storage medium, sample-collection measuring apparatus, component, database, computer program, digital landscape, tracking device” to perform the noted steps that iteratively takes input data and analyzes said data to determine an output to performing generic computer functions, for determining a recommended treatment such that it amounts no more than adding the words "apply it" (or an equivalent) with the judicial exception, or mere instructions to implement an abstract idea on a computer, or merely uses a computer as a tool to perform an abstract idea, see MPEP 2106.05(f), adding insignificant extra-solution activity to the judicial exception, (i.e. “obtaining an oral sample from the subject, measuring and testing/ assaying for...”), and mere data gathering that does not add a meaningful limitation to the above abstract idea, see MPEP 2106.05(d)-(g). As set forth in the 2019 Eligibility Guidance, 84 Fed. Reg. at 55 "merely include[ing] instructions to implement an abstract idea on a computer" is an example of when an abstract idea has not been integrated into a practical application. Accordingly, looking at the claim as a whole, individually and in combination, these additional elements do not integrate the abstract idea into a practical application because they do not impose any meaningful limits on practicing the abstract idea. The claim is directed to an abstract idea. Under step 2B, the claims do not include additional elements that are sufficient to amount to "significantly more" than the judicial exception because as mentioned above, the additional elements amount to no more than generic computing components, recited at a high level of generality, do not present improvements to another technology or technical field, nor do they affect an improvement to the functioning of the computer itself, that amount to no more than mere instruction to perform the abstract idea such that it amounts no more than adding the words "apply it" (or an equivalent) to apply the exception using generic computer component, see MPEP 2106.05(f) and adding insignificant extra-solution activity to the judicial exception, (i.e., “obtaining an oral sample from the subject, measuring and testing/ assaying for...”), and mere data gathering that does not add a meaningful limitation to the above abstract idea, see MPEP 2106.05(d)-(g) and Exergen Corp.; Sequenom, 788 F.3d at 1377-78, 115 USPQ2d at 1157); and Cleveland Clinic Foundation 859 F.3d at 1362, 123 USPQ2d at 1088. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation and mere instructions to apply an exception using a generic computer component cannot provide an inventive concept, See Alice, 573 U.S. at 223 ("mere recitation of a generic computer cannot transform a patent-ineligible abstract idea into a patent-eligible invention."). The claims as a whole are therefore directed to an abstract idea and are not patent eligible. Dependent Claim 2 include all of the limitations of claim(s) 1, and therefore likewise incorporate the above-described abstract idea. While the depending claims add additional limitations, such as As for claims 2, the claim(s) recite limitations that are under the broadest reasonable interpretation, further define the abstract idea noted in the independent claim(s) that covers a performing the steps by a human actor arranging/organizing patient data, which is a certain methods of organizing human activity along with mathematical concepts, but for, the recitation of the generic computer components which are similarly rejected because, neither of the claims, further, defined the abstract idea and do not further limit the claim to a practical application or provide an inventive concept such that the claims are subject matter eligible. Mere instructions to apply an exception using a generic computer component cannot provide an inventive concept ("significantly more"). Regarding Claim 5 (Withdrawn), A device wearable by a subject, comprising:(i) at least one oral-cavity based biosensor; (ii) a wireless receiver for receiving data from the biosensor; (iii) a wireless transmitter; (iv) a processor of the data; and (v) a computer-readable storage medium; wherein the wireless transmitter is configured to transmit data: from the receiver to the processor, to the computer-readable storage medium, or to a user. Subject Matter Free of Prior Art Claims 1-4 have been found by the examiner to be free of prior art. A thorough search of prior art was conducted, and the examiner could not find a single reference or combination of references with adequate rationale to combine that would teach the claimed invention. Specifically, the examiner finds that the language “superimposing/ superimposes the initial and the ideal digital landscapes and calculating, in silico, simulated movement paths between the initial untreated data points and the ideal wellness target endpoints” in claim 1 and 3 to be free of prior art. In the examiner's search of prior art, the following references were found to be the closest prior art: - US 20080162352 “Gizewski” discloses a health maintenance system for comprehensive health assessment, abnormality detection, health monitoring, health pattern and trend detection, health strategy development, and health history archiving, to determine the effectiveness and adequacy, of the health maintenance system, and to make continuous improvements), analysis and assessment of data collected to calculate, using central data processing unit, probability of success (condition will improve) or failure of the program based on evaluating the steps taken by the individual that determines his/her progress to achieve the prescribed objective and tailor the treatment. - US 2012/0116799 – “Lindskog”” discloses a surgical computing system that determines an autonomous operation parameter and generates a control signal for an autonomous operation based on the autonomous operation parameter and the system comprising a situational awareness system that include a pattern recognition system, or machine learning system (e.g., an artificial neural network) and compliant database. - US 2015/0329908 “Al-Murrani” discloses pattern recognition receptor expression as a measure of systemic health in a subject afflicted with an oral health condition. - US 2002/0004725 “Martin” discloses predicting the likelihood of an entity entering a degraded future state by computing a risk value that reflects that likelihood by evaluation of a function that considers a variety of historic, environmental, and systemic behaviors and conditions. - US 2017/0146532 “SREENIVASAN” discloses determining the presence or severity of oral inflammation, such as gingivitis or periodontitis based on oral sample analysis. - US 2012/0197534 “Kavusi” discloses a portable wellness device including a detector configured to detect at least one biomarker in a biologic sample It have been obvious to one of ordinary skill in the art at the time of filing to have employed the claimed invention because the references taken solely, or in combination, fail to provide the required limitations, and modification of any complementary combination of the references of record would be impermissible. While the prior art does recite features that are similar to the claimed invention for superimposing/ superimposes the initial and the ideal digital landscapes and calculating, in silico, simulated movement paths between the initial untreated data points and the ideal wellness target endpoints. For the foregoing reasons, the examiner finds claims 1-3 as free of prior art. Response to Amendment Applicant's arguments filed 08/20/2026 in response to OA mailed 02/20/2026 have been fully considered by the Examiner and addressed as the following: In the remarks, Applicant argues in substance that: Applicant's arguments with respect to the claim objection on page 6-7. In response to the Applicant Amendment(s), Examiner withdraws the claim objection. Applicant's arguments with respect to the 35 U.S.C. § 112(a) rejection on page 7. In response to the Applicant Amendment(s), Examiner withdraws the 112(a) claim rejection. Applicant's arguments with respect to the 35 U.S.C. § 101 rejection on page 7-8. On page 7-8 of the remarks, the Applicant argues “Applicants are claiming a method and system that integrates a new concept of identifying an oral-systemic link by simultaneously assessing both current and historical dental and medical data... Thus, the claims present significantly more than a simple abstract idea and generic computer components”, Examiner respectfully disagree. Examiner respectfully asserts that the claims are given their broadest reasonable interpretation for the purpose of determining whether they encompass a judicial exception. The argued steps are still recite a process that can be performed by a human interacting with computing device performing data analysis clinical data of a user to identify associated risk, determine and tracking treatment plan displayed to the user, but for the fact that the claims recite a general-purpose computer processor to implement the abstract idea for which both the instant claims and the abstract idea are defined as Certain Methods of Organizing Human Activity. The claim(s) limitations which identified the abstract idea are and merely implemented on a computing components that does not integrate the claim into a practical application and does not improve a computing system or technical field that does not transform an abstract idea into a patentable invention rather than just using the computing component as a tool to perform the displaying of patient data and actions to be taken. These features listed in the claims, are not considered an improvement to another technology, or technical field, or an improvement to the functioning of the computer itself rather describes an improvement to the identified abstract idea which is solving a health facility/personnel administrative and clinical issue for arranging and organizing patient/clinical data and tracking treatment plan progress. By relying on computing devices to perform routine tasks more quickly or more accurately is insufficient to render a claim patent eligible (See Alice, 134 S. Ct. at 2359 "use of a computer to create electronic records, track multiple transactions, and issue simultaneous instructions" is not an inventive concept). Even when considering the additional elements such as readable medium, apparatus/component, database, the additional element recited at a high level of generality performed by the processor recited at as a tool to perform the claimed step(s), that amounts to no more than mere instructions using a generic computer component and no more than adding the words "apply it", see MPEP 2106.05(f). The claims as a whole, individually and in combination, provide no integration of the abstract ideas into a practical application that no meaningful limits on practicing the abstract idea are introduced, see MPEP 2106. The claims as a whole are therefore directed to an abstract idea. Therefore, the elements of the instant process, when taken alone, each execute in a manner conventionally expected of these elements. The elements of the instant process, when taken in combination, together do not offer substantially more than the sum of the functions of the elements when each is taken alone. Hence, these additional elements do not add anything significantly more than an abstract idea. Therefore, the Examiner has addressed the Applicant argument(s) and found this argument is not found to be persuasive. Hence, Examiner remains the 101 rejections of claims which have been updated to address Applicant's amendments. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALAAELDIN ELSHAER whose telephone number is (571)272-8284. The examiner can normally be reached M-Th 8:30-5:30. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, MAMON OBEID can be reached at Mamon.Obeid@USPTO.GOV. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALAAELDIN M. ELSHAER/Primary Examiner, Art Unit 3687
Read full office action

Prosecution Timeline

Feb 12, 2025
Application Filed
Feb 20, 2026
Non-Final Rejection mailed — §101
Aug 20, 2026
Response Filed
Oct 01, 2026
Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12749580
SYSTEMS, METHODS AND DEVICES FOR PREDICTING PERSONALIZED BIOLOGICAL STATE, PREDICTING PERSONALIZED BEHAVIOR, AND RECOMMENDING PERSONALIZED BEHAVIOR WITH MODELS PRODUCED WITH META-LEARNING
4y 4m to grant Granted Sep 29, 2026
Patent 12706197
DETERMINATION OF A TREATMENT RESPONSE INDEX
2y 1m to grant Granted Aug 11, 2026
Patent 12700496
AUGMENTING HEALTHCARE STEWARDSHIP USING MACHINE LEARNING
1y 4m to grant Granted Aug 04, 2026
Patent 12694959
DIGITAL THERAPEUTIC SYSTEMS AND METHODS
2y 0m to grant Granted Jul 28, 2026
Patent 12682642
SYSTEM AND METHOD FOR PATIENT MANAGEMENT USING MULTI-DIMENSIONAL ANALYSIS AND COMPUTER VISION
4y 8m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
36%
Grant Probability
66%
With Interview (+29.8%)
3y 1m (~1y 5m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 223 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month